Cover Image

Vascularized composite xenotransplantation: where we have been and where we could go?

Vascularized composite allotransplantation (VCA) enables functional and aesthetic reconstruction after complex tissue loss but remains limited by donor scarcity and immunosuppression. Xenotransplantation, using tissues from other species, offers a potential solution. While progress in solid organ xe...

Full description

Saved in:
Bibliographic Details
Main Authors: Niederegger, Tobias (Author) , Schaschinger, Thomas (Author) , Hundeshagen, Gabriel (Author) , Knoedler, Samuel (Author) , Brandt, Jule (Author) , Voss, Jan O. (Author) , Heiland, Max (Author) , Cetrulo, Curtis L. (Author) , Lellouch, Alexandre G. (Author) , Knoedler, Leonard (Author)
Format: Article (Journal)
Language:English
Published: January-December 2026
In: Cell transplantation
Year: 2026, Volume: 35, Pages: 1-13
ISSN:1555-3892
DOI:10.1177/09636897261431041
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1177/09636897261431041
Verlag, kostenfrei, Volltext: https://journals.sagepub.com/doi/full/10.1177/09636897261431041
Get full text
Author Notes:Tobias Niederegger, Thomas Schaschinger, Gabriel Hundeshagen, Samuel Knoedler, Jule C. Brandt, Jan O. Voss, Max Heiland, Curtis L. Cetrulo, Alexandre G. Lellouch, and Leonard Knoedler
Description
Summary:Vascularized composite allotransplantation (VCA) enables functional and aesthetic reconstruction after complex tissue loss but remains limited by donor scarcity and immunosuppression. Xenotransplantation, using tissues from other species, offers a potential solution. While progress in solid organ xenografts has accelerated, vascularized composite xenotransplantation (VCX) remains largely experimental. This study presents the first systematic review of VCX, tracing its development over the past century and preclinical efforts to overcome immunologic and technical barriers. A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines searched PubMed, EMBASE, Cochrane, Web of Science, and Google Scholar for English-language VCX studies. Methodological quality was assessed using the Newcastle-Ottawa Scale, SYRCLE Risk of Bias tool, and Oxford Levels of Evidence. Of 257 records, six preclinical studies (1885-2023) met inclusion criteria. Donor species included pigs, rabbits, dogs, and humans; recipients were rodents or nonhuman primates. Most used heterotopic grafts (e.g., limbs, groin flaps, thymosternal blocks) combining skin, muscle, bone, and nerves. Techniques included cryopreservation, microsurgical anastomosis, and genetically modified pig grafts (e.g., GalTKO.hCD46). All demonstrated short-term survival without long-term function. Despite technical feasibility, VCX remains experimental. Advances in gene editing, immune modulation, and tissue engineering are essential for clinical translation and may ultimately redefine reconstructive transplantation.
Item Description:Online veröffentlicht am: 18. März 2026
Gesehen am 25.08.2026
Physical Description:Online Resource
ISSN:1555-3892
DOI:10.1177/09636897261431041

Similar Items